Meeting
2024 ASCO Annual Meeting
Harmonizing cancer care delivery for AYAs with osteosarcoma: Comparison of pediatric and medical oncology approaches in a single center.
Authors
Ariel Nash
Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
Ariel Nash , Ravin Ratan , Neeta Somaiah , Anthony Paul Conley , Valerae O. Lewis , Wei-Lien Wang , Heather Y. Lin , Najat C. Daw , Jonathan Benjamin Gill , Douglas James Harrison , Richard Greg Gorlick , Shreyaskumar Patel , J. Andrew Livingston
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 10039)
DOI
10.1200/JCO.2024.42.16_suppl.10039
Abstract #
10039
Poster Bd #
406
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate as neoadjuvant therapy for osteosarcoma: A single-arm, exploratory phase II trial.
First Author: Qinglian Tang
Poster
2013 ASCO Annual Meeting
Switching chemotherapy in adult osteosarcoma patients with poor necrosis rates post neoadjuvant methotrexate, cisplatin, and doxorubicin (MAP).
First Author: Grainne O'Kane
Poster
2022 ASCO Annual Meeting
Gemcitabine-docetaxel in patients with relapsed high-grade osteosarcoma after first-line treatment with high-dose ifosfamide: A retrospective multicenter study.
First Author: Maria Grazia Pionelli
Poster
2019 ASCO Annual Meeting
Multi-institutional analysis of outcomes in patients with dedifferentiated chondrosarcoma (DDCS).
First Author: Nam Bui